🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to learn about how itraconazole and rifam...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2020-02-12
Trial ID
NCT05134337
Treatments Being Tested
This study is being done to evaluate the safety, tolerability and antitumor...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2020-10-06
Trial ID
NCT04477291
Treatments Being Tested
The purpose of this study is to find out whether the study drug, LOXO-338, ...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2021-09-30
Trial ID
NCT05024045
Treatments Being Tested
The main purpose of this study is to evaluate the effect of Pirtobrutinib (...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2021-03-11
Trial ID
NCT06194214
Treatments Being Tested
This is a study for participants with a type of blood cancer called mantle ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Start Date
2021-04-08
Trial ID
NCT04662255
Treatments Being Tested
This phase II trial studies how well pirtobrutinib and venetoclax work in t...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2023-01-31
Trial ID
NCT05677919
The main purpose of this study is to measure how much of pirtobrutinib (LOX...
Status
Completed
Location
Orange County Research Institute
Start Date
2021-02-01
Trial ID
NCT06190678
Treatments Being Tested
The master protocol study J2N-MC-JZNY provides a framework to enable the ev...
Status
Recruiting
Location
Cancer Specialists, LLC
Start Date
2025-05-20
Trial ID
NCT06876649
Treatments Being Tested
This study is being done to examine the safety and effectiveness of pirtobr...
Status
Active Not Recruiting
Location
Beth Israel Deaconness Medical
Start Date
2023-05-02
Trial ID
NCT05734495
Treatments Being Tested
This phase II trial tests the safety and effectiveness of glofitamab given ...
Status
Recruiting
Location
University of California, Davis
Start Date
2024-06-11
Trial ID
NCT06252675